Form 4: Outset Medical SVP Marc Nash Sells Shares to Cover Tax Obligations

SVP of Operations and R&D at Outset Medical, Marc Nash, sold shares to cover tax withholding obligations related to vesting RSUs.

Summary

• On March 15, 2024, Marc Nash, SVP of Operations and R&D at Outset Medical, sold 2,391 shares of common stock at a price of $2.13 per share to cover tax withholding obligations.
• This sale was related to the vesting of 6,399 shares of common stock underlying RSUs granted on March 15, 2023.
• The sale was executed as a 'sell to cover' transaction to satisfy tax obligations and does not represent a discretionary trade.
• Following the transaction, Nash beneficially owns 242,510 shares of Outset Medical common stock, which includes 1,801 shares acquired through the company's Employee Stock Purchase Plan (ESPP) for the purchase period of September 1, 2023, to February 29, 2024.

Sentiment

Score: 5

Explanation: The document reports a routine transaction (sell to cover taxes) and acquisition of shares through ESPP, indicating a neutral sentiment.

Positives

• The reporting person acquired 1,801 shares of Common Stock pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ('ESPP'), for the purchase period of September 1, 2023 to February 29, 2024.

Industry Context

Insider transactions are routinely monitored and reported to the SEC. Sales to cover taxes on vesting equity are common and don't necessarily reflect a negative outlook on the company.

Stakeholder Impact

• The sale of shares could have a minor negative impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the relatively small number of shares sold.

Key Dates